Acalabrutinib versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia : final ASCEND trial results

2022
journal article
article
33
dc.cm.date2022-12-28T23:16:26Z
dc.cm.id110742pl
dc.cm.idOmegaUJCM104534b47f574efdb777afdc4de7cd2apl
dc.contributor.authorGhia, Paolopl
dc.contributor.authorPluta, Andrzejpl
dc.contributor.authorWach, Małgorzatapl
dc.contributor.authorLysak, Danielpl
dc.contributor.authorSimkovic, Martinpl
dc.contributor.authorKriachok, Irynapl
dc.contributor.authorIlles, Arpadpl
dc.contributor.authorde la Serna, Javierpl
dc.contributor.authorDolan, Seanpl
dc.contributor.authorCampbell, Philippl
dc.contributor.authorMusuraca, Gerardopl
dc.contributor.authorJacob, Abrahampl
dc.contributor.authorAvery, Eric J.pl
dc.contributor.authorLee, Jae Hoonpl
dc.contributor.authorUsenko, Gannapl
dc.contributor.authorWang, Min Huipl
dc.contributor.authorYu, Tingpl
dc.contributor.authorJurczak, Wojciech - 129923 pl
dc.date.accession2022-12-28pl
dc.date.accessioned2022-12-28T23:16:26Z
dc.date.available2022-12-28T23:16:26Z
dc.date.issued2022pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number12pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume6pl
dc.identifier.articleide801pl
dc.identifier.doi10.1097/HS9.0000000000000801pl
dc.identifier.eissn2572-9241pl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/305308
dc.identifier.weblinkhttps://journals.lww.com/hemasphere/Fulltext/2022/12000/Acalabrutinib_Versus_Investigator_s_Choice_in.4.aspxpl
dc.languageengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceCC-BY-NC-ND
dc.rights.uri*
dc.share.typeOtwarte czasopismo
dc.subtypeArticlepl
dc.titleAcalabrutinib versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia : final ASCEND trial resultspl
dc.title.journalHemaSpherepl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.cm.date
2022-12-28T23:16:26Z
dc.cm.idpl
110742
dc.cm.idOmegapl
UJCM104534b47f574efdb777afdc4de7cd2a
dc.contributor.authorpl
Ghia, Paolo
dc.contributor.authorpl
Pluta, Andrzej
dc.contributor.authorpl
Wach, Małgorzata
dc.contributor.authorpl
Lysak, Daniel
dc.contributor.authorpl
Simkovic, Martin
dc.contributor.authorpl
Kriachok, Iryna
dc.contributor.authorpl
Illes, Arpad
dc.contributor.authorpl
de la Serna, Javier
dc.contributor.authorpl
Dolan, Sean
dc.contributor.authorpl
Campbell, Philip
dc.contributor.authorpl
Musuraca, Gerardo
dc.contributor.authorpl
Jacob, Abraham
dc.contributor.authorpl
Avery, Eric J.
dc.contributor.authorpl
Lee, Jae Hoon
dc.contributor.authorpl
Usenko, Ganna
dc.contributor.authorpl
Wang, Min Hui
dc.contributor.authorpl
Yu, Ting
dc.contributor.authorpl
Jurczak, Wojciech - 129923
dc.date.accessionpl
2022-12-28
dc.date.accessioned
2022-12-28T23:16:26Z
dc.date.available
2022-12-28T23:16:26Z
dc.date.issuedpl
2022
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
12
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
6
dc.identifier.articleidpl
e801
dc.identifier.doipl
10.1097/HS9.0000000000000801
dc.identifier.eissnpl
2572-9241
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/305308
dc.identifier.weblinkpl
https://journals.lww.com/hemasphere/Fulltext/2022/12000/Acalabrutinib_Versus_Investigator_s_Choice_in.4.aspx
dc.languagepl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
dc.share.type
Otwarte czasopismo
dc.subtypepl
Article
dc.titlepl
Acalabrutinib versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia : final ASCEND trial results
dc.title.journalpl
HemaSphere
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
2
Views per month
Views per city
Beijing
2

No access

No Thumbnail Available